Hypermuscular mice with mutation in the myostatin gene display altered calcium signalling

摘要

Abstract Myostatin, a member of the transforming growth factor beta family, is a potent negative regulator of skeletal muscle growth, as myostatin-deficient mice show a great increase in muscle mass. Yet the physical performance of these animals is reduced. As an explanation for this, alterations in the steps in excitation-contraction coupling were hypothesized and tested for in mice with the 12 bp deletion in the propeptide region of the myostatin precursor (MstnCmPt~dllAbc or Cmpt). In voluntary wheel running, control C57BL/6 mice performed better than the mutant animals in both maximal speed and total distance covered. Despite the previously described lower specific force of Cmpt animals, the pea-force relationship, determined on chemically permeabilized fibre segments, did not show any significant difference between the two mouse strains. While resting intracellular Ca~(2+) concentration ([Ca~(2+)]i) measured on single intact flexor digitorum brevis (FDB) muscle fibres using Fura-2 AM was similar to control (72.0 +-1.7 vs. 78.1 +- 2.9 nM, n = 38 and 45), the amplitude of KCl-evoked calcium transients was smaller (360 dz 49 vs. 222 +- 45 nM, n = 22) in the mutant strain. Similar results were obtained using tetanic stimulation and Rhod-2 AM, which gave calcium transients that were smaller (2.42 dz 0.11 vs. 2.06 +- 0.10 AF/F_0, n = 14 and 13, respectively) on Cmpt mice. Sarcoplasmic reticulum (SR) calcium release flux calculated from these transients showed a reduced peak (23.7 +- 3.0 vs. 15.8 +- 2.1 mMs~(-1)) and steady level (5.7 +- 0.7 vs. 3.7 +- 0.5 mM s~(-1)) with no change in the peak-to-steady ratio. The amplitude and spatial spread pf calcium release events detected on permeabilized FDB fibres were also significantly smaller in mutant mice. These results suggest that reduced SR calcium release underlies the reduced muscle force in Cmpt animals.